BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15942942)

  • 1. PAX5/IGH rearrangement is a recurrent finding in a subset of aggressive B-NHL with complex chromosomal rearrangements.
    Poppe B; De Paepe P; Michaux L; Dastugue N; Bastard C; Herens C; Moreau E; Cavazzini F; Yigit N; Van Limbergen H; De Paepe A; Praet M; De Wolf-Peeters C; Wlodarska I; Speleman F
    Genes Chromosomes Cancer; 2005 Oct; 44(2):218-23. PubMed ID: 15942942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-grade B-Cell lymphomas with plasmacytic differentiation lack PAX5 gene rearrangements.
    George TI; Wrede JE; Bangs CD; Cherry AM; Warnke RA; Arber DA
    J Mol Diagn; 2005 Aug; 7(3):346-51. PubMed ID: 16049306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of IGH rearrangements in non-Hodgkin's B-cell lymphomas by fluorescence in situ hybridization.
    Bernicot I; Douet-Guilbert N; Le Bris MJ; Morice P; Abgrall JF; Berthou C; Morel F; De Braekeleer M
    Anticancer Res; 2005; 25(5):3179-82. PubMed ID: 16101124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of PAX5 rearrangements in lymphoplasmacytic lymphomas: reassessing the reported association with t(9;14).
    Cook JR; Aguilera NI; Reshmi-Skarja S; Huang X; Yu Z; Gollin SM; Abbondanzo SL; Swerdlow SH
    Hum Pathol; 2004 Apr; 35(4):447-54. PubMed ID: 15116325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse large B-cell lymphoma carrying t(9;14)(p13;q32)/PAX5-immunoglobulin heavy chain gene is characterized by nuclear positivity of MUM1 and PAX5 by immunohistochemistry.
    Ohno H; Nakagawa M; Kishimori C; Fukutsuka K; Maekawa F; Takeoka K; Hayashida M; Sakamoto S; Akasaka T; Honjo G
    Hematol Oncol; 2020 Apr; 38(2):171-180. PubMed ID: 31955451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal rearrangement of the PAX-5 locus in lymphoplasmacytic lymphoma with t(9;14)(p13;q32).
    Iida S; Rao PH; Ueda R; Chaganti RS; Dalla-Favera R
    Leuk Lymphoma; 1999 Jun; 34(1-2):25-33. PubMed ID: 10350329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cytogenetics of IGH rearrangements in non-Hodgkin B-cell lymphoma.
    Bernicot I; Douet-Guilbert N; Le Bris MJ; Herry A; Morel F; De Braekeleer M
    Cytogenet Genome Res; 2007; 118(2-4):345-52. PubMed ID: 18000389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the PAX5/BSAP transcription factor in haematological tumour cells and further molecular characterization of the t(9;14)(p13;q32) translocation in B-cell non-Hodgkin's lymphoma.
    Hamada T; Yonetani N; Ueda C; Maesako Y; Akasaka H; Akasaka T; Ohno H; Kawakami K; Amakawa R; Okuma M
    Br J Haematol; 1998 Aug; 102(3):691-700. PubMed ID: 9722295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary ocular adnexal lymphoproliferative lesions: clinicopathologic features and genetic alterations].
    Dong LN; Liu HG; Jin HS; Ye HT; Gao ZF; Zhou XG; Dong GH; Zhang DD; Gong LP
    Zhonghua Bing Li Xue Za Zhi; 2008 Dec; 37(12):809-14. PubMed ID: 19159526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deregulated PAX-5 transcription from a translocated IgH promoter in marginal zone lymphoma.
    Morrison AM; Jäger U; Chott A; Schebesta M; Haas OA; Busslinger M
    Blood; 1998 Nov; 92(10):3865-78. PubMed ID: 9808580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An additional segment at 1p36 derived from der(18)t(14;18) in patients with diffuse large B-cell lymphomas transformed from follicular lymphoma.
    Nomura K; Kanda-Akano Y; Shimizu D; Okuda T; Yoshida N; Matsumoto Y; Nishida K; Taki T; Yokota S; Horiike S; Taniwaki M
    Ann Hematol; 2005 Jul; 84(7):474-6. PubMed ID: 15700138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The t(9;14)(p13;q32) translocation in B-cell non-Hodgkin's lymphoma.
    Ohno H; Ueda C; Akasaka T
    Leuk Lymphoma; 2000 Feb; 36(5-6):435-45. PubMed ID: 10784387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas.
    Bertrand P; Bastard C; Maingonnat C; Jardin F; Maisonneuve C; Courel MN; Ruminy P; Picquenot JM; Tilly H
    Leukemia; 2007 Mar; 21(3):515-23. PubMed ID: 17230227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic role of Pax5 in the T-lymphoid lineage upon ectopic expression from the immunoglobulin heavy-chain locus.
    Souabni A; Jochum W; Busslinger M
    Blood; 2007 Jan; 109(1):281-9. PubMed ID: 16968900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New chromosome abnormalities and lack of BCL-6 gene rearrangements in Argentinean diffuse large B-cell lymphomas.
    Cerretini R; Noriega MF; Narbaitz M; Slavutsky I
    Eur J Haematol; 2006 Apr; 76(4):284-93. PubMed ID: 16519699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular cytogenetic analysis of chromosomal breakpoints in the IGH, MYC, BCL6, and MALT1 gene loci in primary cutaneous B-cell lymphomas.
    Hallermann C; Kaune KM; Gesk S; Martin-Subero JI; Gunawan B; Griesinger F; Vermeer MH; Santucci M; Pimpinelli N; Willemze R; Siebert R; Neumann C
    J Invest Dermatol; 2004 Jul; 123(1):213-9. PubMed ID: 15191563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent translocation of BCL2 and MYC with a single immunoglobulin locus in high-grade B-cell lymphomas.
    Knezevich S; Ludkovski O; Salski C; Lestou V; Chhanabhai M; Lam W; Klasa R; Connors JM; Dyer MJ; Gascoyne RD; Horsman DE
    Leukemia; 2005 Apr; 19(4):659-63. PubMed ID: 15716988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAX5-positive plasma cell myeloma with t(9;14;11)(p13;q32;q13), a novel complex variant translocation of t(11;14)(q13;q32) and t(9;14)(p13;q32).
    Sato K; Sakai H; Kato M; Nishio Y; Tsuruoka Y; Uemura Y; Yokoi S; Saito T; Matsunawa M; Suzuki Y; Isobe Y; Inoue Y; Takahashi M; Miura I
    Int J Hematol; 2015 Jun; 101(6):608-11. PubMed ID: 25633778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomorphologic findings of B-cell lymphomas with concurrent IGH/BCL2 and MYC rearrangements (dual-translocation lymphomas).
    da Cunha Santos G; Ko HM; Saieg MA; Boerner SL; Lai SW; Bailey D; Geddie WR
    Cancer Cytopathol; 2011 Aug; 119(4):254-62. PubMed ID: 21560251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The spectrum of B-cell non-Hodgkin lymphomas with dual IgH-BCL2 and BCL6 translocations.
    Keller CE; Nandula S; Fisher J; Subramaniyam S; Vakiani E; Savage DG; Murty VV; Alobeid B; Bhagat G
    Am J Clin Pathol; 2008 Aug; 130(2):193-201. PubMed ID: 18628087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.